Package 70121-1237-1

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 70121-1237-1
Digits Only 7012112371
Product NDC 70121-1237
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (70121-1237-1)

Marketing

Marketing Status
Marketed Since 2022-02-09
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "38a5005c-7a0b-48c6-bba5-a996ccf1c847", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["80a43736-0598-4e4b-85ba-e29daa290c8f"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (70121-1237-1)", "package_ndc": "70121-1237-1", "marketing_start_date": "20220209"}], "brand_name": "AZACITIDINE", "product_id": "70121-1237_38a5005c-7a0b-48c6-bba5-a996ccf1c847", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "70121-1237", "generic_name": "AZACITIDINE", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZACITIDINE", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA211549", "marketing_category": "ANDA", "marketing_start_date": "20220209", "listing_expiration_date": "20261231"}